Literature DB >> 36063181

Primary sclerosing cholangitis: review for radiologists.

Matthew A Morgan1, Rachita Khot2, Karthik M Sundaram3, Daniel R Ludwig4, Rashmi T Nair5, Pardeep K Mittal6, Dhakshina M Ganeshan7, Sudhakar K Venkatesh8.   

Abstract

Primary sclerosing cholangitis is a rare chronic inflammatory disease affecting the bile ducts, which can eventually result in bile duct strictures, cholestasis and cirrhosis. Patients are often asymptomatic but may present with clinical features of cholestasis. Imaging plays an important role in the diagnosis and management. This review covers the pathophysiology, clinical features, imaging findings as well as methods of surveillance and post-transplant appearance.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Biliary; Cholangitis; Elastography; Liver; MRI; Primary sclerosing cholangitis

Year:  2022        PMID： 36063181     DOI： 10.1007/s00261-022-03655-6

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  66 in total

Review 1.  The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies.

Authors:  Ulrich Beuers; Simon Hohenester; Lucas J Maillette de Buy Wenniger; Andreas E Kremer; Peter L M Jansen; Ronald P J Oude Elferink
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

2.  Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis.

Authors:  Gerda Rudolph; Daniel Gotthardt; Petra Klöters-Plachky; Hasan Kulaksiz; Daniel Rost; Adolf Stiehl
Journal:  J Hepatol       Date:  2009-03-27       Impact factor: 25.083

Review 3.  Update on primary sclerosing cholangitis.

Authors:  Roger W Chapman
Journal:  Clin Liver Dis (Hoboken)       Date:  2017-05-26

Review 4.  Genetics of primary sclerosing cholangitis and pathophysiological implications.

Authors:  Xiaojun Jiang; Tom H Karlsen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-15       Impact factor: 46.802

5.  Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.

Authors:  Annika Bergquist; Anders Ekbom; Rolf Olsson; Dan Kornfeldt; Lars Lööf; Ake Danielsson; Rolf Hultcrantz; Stefan Lindgren; Hanne Prytz; Hanna Sandberg-Gertzén; Sven Almer; Fredrik Granath; Ulrika Broomé
Journal:  J Hepatol       Date:  2002-03       Impact factor: 25.083

6.  Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.

Authors:  Kirsten Boonstra; Rinse K Weersma; Karel J van Erpecum; Erik A Rauws; B W Marcel Spanier; Alexander C Poen; Karin M van Nieuwkerk; Joost P Drenth; Ben J Witteman; Hans A Tuynman; Anton H Naber; Paul J Kingma; Henk R van Buuren; Bart van Hoek; Frank P Vleggaar; Nan van Geloven; Ulrich Beuers; Cyriel Y Ponsioen
Journal:  Hepatology       Date:  2013-10-17       Impact factor: 17.425

7.  Global incidence, prevalence and features of primary sclerosing cholangitis: A systematic review and meta-analysis.

Authors:  Tej I Mehta; Simcha Weissman; Brian M Fung; John Sotiriadis; Keith D Lindor; James H Tabibian
Journal:  Liver Int       Date:  2021-07-05       Impact factor: 5.828

Review 8.  Primary sclerosing cholangitis.

Authors:  Jessica K Dyson; Ulrich Beuers; David E J Jones; Ansgar W Lohse; Mark Hudson
Journal:  Lancet       Date:  2018-02-13       Impact factor: 79.321

9.  Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.

Authors:  Sun-Gou Ji; Brian D Juran; Sören Mucha; Trine Folseraas; Luke Jostins; Espen Melum; Natsuhiko Kumasaka; Elizabeth J Atkinson; Erik M Schlicht; Jimmy Z Liu; Tejas Shah; Javier Gutierrez-Achury; Kirsten M Boberg; Annika Bergquist; Severine Vermeire; Bertus Eksteen; Peter R Durie; Martti Farkkila; Tobias Müller; Christoph Schramm; Martina Sterneck; Tobias J Weismüller; Daniel N Gotthardt; David Ellinghaus; Felix Braun; Andreas Teufel; Mattias Laudes; Wolfgang Lieb; Gunnar Jacobs; Ulrich Beuers; Rinse K Weersma; Cisca Wijmenga; Hanns-Ulrich Marschall; Piotr Milkiewicz; Albert Pares; Kimmo Kontula; Olivier Chazouillères; Pietro Invernizzi; Elizabeth Goode; Kelly Spiess; Carmel Moore; Jennifer Sambrook; Willem H Ouwehand; David J Roberts; John Danesh; Annarosa Floreani; Aliya F Gulamhusein; John E Eaton; Stefan Schreiber; Catalina Coltescu; Christopher L Bowlus; Velimir A Luketic; Joseph A Odin; Kapil B Chopra; Kris V Kowdley; Naga Chalasani; Michael P Manns; Brijesh Srivastava; George Mells; Richard N Sandford; Graeme Alexander; Daniel J Gaffney; Roger W Chapman; Gideon M Hirschfield; Mariza de Andrade; Simon M Rushbrook; Andre Franke; Tom H Karlsen; Konstantinos N Lazaridis; Carl A Anderson
Journal:  Nat Genet       Date:  2016-12-19       Impact factor: 38.330

10.  Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.

Authors:  João Sabino; Sara Vieira-Silva; Kathleen Machiels; Marie Joossens; Gwen Falony; Vera Ballet; Marc Ferrante; Gert Van Assche; Schalk Van der Merwe; Severine Vermeire; Jeroen Raes
Journal:  Gut       Date:  2016-05-20       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.